US Material Events SEC 8-K Filings — June 23, 2026

23-06-2026

Hawkeye Systems, Inc. (HWKE) filed an 8-K on June 23, 2026, reporting multiple corporate actions approved on June 17, 2026. The company dismissed its independent auditor Fruci & Associates II, PLLC and appointed Grassi & Co., CPAs, P.C. as its new auditor, with no disagreements or reportable events in prior audits. Stockholders approved a name change to Hawkeye Digital, Inc., a massive increase in authorized shares from 450 million to 10.05 billion (including a 10 billion common stock authorization), a reverse stock split (1-for-2 to 1-for-20), and the adoption of the 2026 Equity Incentive Plan. The majority stockholder, Hawkeye Holdco, LLC, holding ~90.1% of voting power, consented to all proposals. No financial results or period-over-period comparisons were provided in this filing.

• · The reverse stock split ratio is not less than 1-for-2 nor greater than 1-for-20, with implementation at the Board's discretion before June 17, 2027.
• · The Amended and Restated Articles of Incorporation will become effective 21 days after the Information Statement is mailed to stockholders.
• · The 2026 Equity Incentive Plan allows for Incentive Stock Options, Non-qualified Stock Options, Stock Appreciation Rights, Restricted Awards, Performance Share Awards, Cash Awards, and Other Equity-Based Awards.
• · No disagreements or reportable events occurred with the former auditor during the audits for fiscal years ended June 30, 2024 and 2025, or through June 17, 2026.
• · The company is not an emerging growth company.

23-06-2026

Eureka Acquisition Corp (SPAC) filed an 8-K on June 23, 2026, disclosing Amendment No. 1 to its Business Combination Agreement with Marine Thinking Inc., dated June 12, 2026. The amendment updates the post-closing board composition to eight directors, with seven designated by the Company, one by the IPO Sponsor, and at least five of the eight required to be Canadian citizens. The existing agreement remains in effect with the amendment prevailing in case of conflict.

• · Amendment executed on June 12, 2026, amending the original Business Combination Agreement dated October 29, 2025.
• · Post-closing board will consist of eight directors: seven designated by the Company (including four independent and one financial expert), one by the IPO Sponsor, and at least five must be Canadian citizens.
• · The amendment was signed by Fen Zhang for the SPAC and Amalgamation Sub, and by Lishao Wang for the Company.

23-06-2026

Data I/O Corporation announced the closing of a $9 million investment from two institutional investors, consisting of common stock, convertible debentures, and warrants. The funds are intended for working capital, general corporate purposes, and potential strategic acquisitions. However, the financing is subject to stockholder approval for full conversion and warrant exercise, and the securities are unregistered, posing resale restrictions.

• · Warrants have an exercise price of $3.00 per share and a 5-year term.
• · Convertible debentures are unsecured and mature on the fifth anniversary of issuance.
• · Series B preferred stock is non-voting and convertible into common stock at $2.50 per share.
• · The convertible debentures automatically convert into Series B preferred stock upon stockholder approval at an upcoming shareholders meeting.
• · Data I/O intends to use proceeds for working capital, general corporate purposes, and potential future strategic acquisitions.

23-06-2026

Comscore, Inc. held its annual meeting on June 16, 2026, where stockholders approved an amendment to the 2018 Equity and Incentive Compensation Plan to increase available shares by 3,000,000, and elected two Class I directors (David Kline and Brian Wendling). The compensation of named executive officers was approved on a non-binding advisory basis, and Deloitte & Touche LLP was ratified as the independent auditor for fiscal year 2026. The amendment to the Plan received 19,593,512 votes in favor, 4,117,350 against, and 119,352 abstentions, with 1,240,084 broker non-votes.

• · The amendment to the Plan was approved with 19,593,512 votes in favor, 4,117,350 against, and 119,352 abstentions, plus 1,240,084 broker non-votes.
• · Executive compensation (say-on-pay) received 23,119,135 votes in favor, 659,092 against, and 51,987 abstentions.
• · Ratification of Deloitte & Touche LLP as auditor was approved with 25,048,171 votes in favor, 18,634 against, and 3,493 abstentions.
• · Series C Preferred Stock shares (8,795,201) were required to vote neutrally on all proposals.

23-06-2026

Manulife Private Credit Fund (the Company) is being acquired by John Hancock Comvest Private Income Fund (the Acquiror) through a two-step merger process, with Merger Sub first merging into the Company, followed by the Surviving Company merging into the Acquiror. The transaction, structured as a tax-free reorganization under Section 368(a) of the Code, will see Company shareholders receive Acquiror Class I Common Shares based on a yet-to-be-determined Exchange Ratio after the June 30, 2026 valuation. Both boards have unanimously approved the deal as fair and in the best interests of shareholders, with no dilution expected from the transaction.

• · The merger is structured as a two-step process: first Merger Sub merges into the Company, then the Surviving Company merges into the Acquiror.
• · The transaction is intended to qualify as a reorganization under Section 368(a) of the Internal Revenue Code.
• · Closing will occur on the first day of the month after conditions are satisfied, but no earlier than completion of the June 30, 2026 valuation process.
• · Company Common Shares owned by the Acquiror or its subsidiaries (including Merger Sub) will be cancelled and no consideration will be paid for them.
• · Shareholders will receive cash in lieu of fractional shares of Acquiror Class I Common Shares.
• · The Exchange Ratio will be adjusted for any stock splits, dividends, or reclassifications between the Determination Date and the Effective Time.

23-06-2026

John Hancock Comvest Private Income Fund (Acquiror) has entered into a definitive Agreement and Plan of Merger to acquire Manulife Private Credit Fund (Company) through a two-step merger process, with the Company first merging into a wholly-owned subsidiary and then into the Acquiror. The transaction is structured as a tax-free reorganization under Section 368(a) of the Code, with Company shareholders receiving Acquiror Class I Common Shares based on a formulaic Exchange Ratio tied to net asset values determined after June 30, 2026. The merger is subject to shareholder approvals from both entities and other customary conditions, with the boards of both companies having unanimously approved the transaction as fair and in the best interests of their respective shareholders.

• · The merger is structured as two sequential mergers: first Merger Sub merges into the Company, then the Surviving Company merges into the Acquiror.
• · Company shareholders will receive Acquiror Class I Common Shares at an Exchange Ratio to be finally determined after the June 30, 2026 valuation process.
• · No fractional shares of Acquiror Class I Common Shares will be issued; cash will be paid in lieu of fractional shares.
• · The closing is targeted for the first day of the month after all conditions are satisfied or waived, but no earlier than completion of the June 30, 2026 quarterly valuation.
• · The Company Board and Acquiror Board each unanimously determined the transaction is fair, advisable, and in the best interests of their respective shareholders and that existing shareholders' interests will not be diluted.
• · The parties intend the Mergers to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.

23-06-2026

CVR Energy (CVI) and CVR Partners (UAN) announced the promotion of Dane Neumann from EVP & CFO to President and CEO of both entities, effective June 18, 2026, following Mark Pytosh's resignation for personal reasons. The filing contains no quantitative financial data; the leadership change is the sole material event with forward-looking statements about growth and shareholder returns but no specific metrics or performance comparisons.

• · CVR Energy subsidiaries serve as the general partner and own approximately 37% of the common units of CVR Partners.
• · CVR Partners operates a nitrogen fertilizer manufacturing facility in Coffeyville, Kansas (1,300 ton-per-day ammonia unit, 3,100 ton-per-day UAN unit, dual-train gasifier complex with 89 million standard cubic feet per day hydrogen capacity) and a facility in East Dubuque, Illinois (1,075 ton-per-day ammonia unit, 950 ton-per-day UAN unit).
• · The effective date of the appointment is June 18, 2026, and the announcement was made on June 22, 2026.

23-06-2026

CVR Energy (CVI) and CVR Partners (UAN) announced the promotion of Dane Neumann from Executive Vice President and CFO to President and CEO of both entities and their Boards of Directors, effective June 18, 2026, following Mark Pytosh's resignation for personal reasons. The leadership change is framed as a catalyst for growth and value creation, though no specific financial or operational targets were disclosed, leaving near-term performance expectations uncertain.

• · Resignation of former CEO Mark Pytosh was for personal reasons and effective June 18, 2026.
• · New CEO Dane Neumann previously served as EVP and CFO of the CVR entities.
• · CVR Energy holds approximately 37% of CVR Partners common units.
• · CVR Partners' facilities include Coffeyville, KS (1,300 TPD ammonia, 3,100 TPD UAN, 89 MMSCFD hydrogen) and East Dubuque, IL (1,075 TPD ammonia, 950 TPD UAN).

23-06-2026

Fortress Private Lending Fund, through its borrower FPLF NS Holdings Finance LLC, entered into Amendment No. 3 to its Credit Agreement dated June 17, 2026, with lenders including The Bank of Nova Scotia and Sumitomo Mitsui Trust Bank. The amendment modifies certain terms of the existing credit facility, with all lenders consenting and no defaults continuing. No specific financial figures or performance metrics were disclosed in this filing.

• · The amendment was executed on June 17, 2026, and filed on June 23, 2026.
• · The Credit Agreement was originally dated November 7, 2025, and had been amended twice before (Amendment No. 1 on January 19, 2026; Amendment No. 2 on May 13, 2026).
• · All lenders party to the Credit Agreement consented to this amendment.
• · The Rating Condition was satisfied as a condition precedent to the amendment.
• · The Borrower, Subsidiary Guarantor, and Servicer represented that no Default or Event of Default was continuing and that all Coverage Tests, Concentration Limitations, Collateral Quality Tests, and the Portfolio Advance Rate Test were satisfied both before and after the amendment.

23-06-2026

Nuvectis Pharma announced a strategic portfolio expansion via a license agreement with Haisco Pharmaceutical Group for exclusive ex-China rights to two clinical-stage compounds: NXP100 (a once-daily oral Complement Factor B inhibitor for complement-mediated diseases) and NXP200 (a brain-penetrant paradox-breaker BRAF inhibitor for BRAF-mutated malignancies). The deal includes upfront and near-term payments of up to $40 million, potential milestone payments up to $1.421 billion, and tiered royalties. While NXP100 has shown superior efficacy over eculizumab in Phase 3 PNH trials (59.5% vs 8.3% achieving hemoglobin normalization), the company faces significant financing conditions to meet capital requirements for development, and both compounds are still in clinical stages with no FDA approvals.

• · NXP100 composition of matter patents expire in 2043; NXP200 patents expire in 2042.
• · NXP200 demonstrated a >40% response rate in low- and high-grade adult glioma, including one Complete Response.
• · NXP200 is currently in a Phase 1b study in China; a second-generation salt form shows improved PK and greater clinical activity.
• · Haisco retains rights for NXP100 in India and certain Southeast Asia territories.
• · The agreement is subject to financing conditions that Nuvectis must meet to ensure sufficient capital for development.
• · Fabhalta (iptacopan) is the only FDA-approved Complement Factor B inhibitor, with approvals in PNH, IgAN, and C3G.
• · NXP100 is administered once daily vs Fabhalta's twice-daily dosing.
• · Nuvectis will hold a conference call on June 22, 2026 at 8:30 AM ET.

23-06-2026

Avalo Therapeutics appointed Ron Philip to its Board of Directors effective June 23, 2026. Mr. Philip will serve on the Compensation Committee and Science, Development and Commercial Advisory Committee, and will receive a non-qualified stock option award for 40,200 shares vesting over three years. He brings extensive biotech leadership experience from roles at Orbital Therapeutics, Spark Therapeutics, and Pfizer.

• · Mr. Philip's appointment is effective immediately and he will serve until the 2027 Annual Meeting.
• · He will serve on the Compensation Committee and Science, Development and Commercial Advisory Committee.
• · The stock option vests in three equal annual installments starting June 23, 2027.
• · Mr. Philip served as CEO of Orbital Therapeutics until its acquisition by Bristol-Myers Squibb in December 2025.
• · He previously served as CEO of Spark Therapeutics from May 2017 to August 2024.
• · Mr. Philip holds a B.S. in Computer Information Systems from Drexel University.

23-06-2026

Athene Holding Ltd. appointed Robert Brackenbury, former Deputy CIO of the State of Michigan Retirement System, as an independent director effective June 23, 2026. Brackenbury brings decades of experience overseeing over $170 billion in pension and state trust fund assets, which is expected to strengthen the board's expertise in retirement solutions and investment management.

• · Brackenbury previously served as a Michigan State Tax Tribunal judge and Assistant Attorney General.
• · He also served as a U.S. Army officer on active duty and in the U.S. Army Reserve.
• · He currently serves on investment committees for community foundations in Michigan.
• · Brackenbury holds a B.S. in mathematics and economics, an M.A. in economics from Eastern Michigan University, an MBA from the University of Michigan Ross School of Business, and a J.D. from Wayne State University Law School.
• · He completed the Senior Executives in State and Local Government Program at Harvard Kennedy School.
• · Athene has operations in the United States, Bermuda, Canada, and Japan.

23-06-2026

AMC Entertainment Holdings announced a registered direct offering of 95,250,000 shares of common stock at a price of approximately $2.10 per share, expected to raise gross proceeds of $200 million. The net proceeds will be used to redeem $125.5 million of 6.125% Senior Subordinated Notes due 2027, pay related fees, and for general corporate purposes including debt repayment and strengthening cash reserves. The offering is expected to close on June 24, 2026, with Roth Capital Partners as sole placement agent.

• · The offering is being made under a shelf registration statement on Form S-3 (File No. 333-293291) filed on February 9, 2026.
• · AMC operates approximately 850 theatres and 9,600 screens globally.
• · The company intends to use net proceeds to redeem $125.5 million of 6.125% Senior Subordinated Notes due 2027.

23-06-2026

FMC Corp entered into a framework agreement to sell its Newark, Delaware property to Ercor Elkton, LLC for approximately $114 million in gross cash proceeds, with proceeds expected to be used to pay down debt. The transaction includes a leaseback of actively operated facilities to minimize disruption to research operations at the Stine Research Center. However, the agreement is subject to due diligence and other conditions, and there is no assurance the transaction will close.

• · The property is part of FMC's Stine Research Center campus in Delaware.
• · FMC will retain ownership of the adjacent Maryland property.
• · The transaction is expected to close in Q4 2026.
• · The leaseback agreement terms are still preliminary and subject to negotiation.
• · FMC does not expect any impact to its research and development capabilities.

23-06-2026

Dragonfly Energy Holdings Corp. appointed Lukas Lutz as an independent director and member of the Nominating and Corporate Governance Committee, effective June 18, 2026, replacing Brian Nelson. Mr. Lutz received 10,000 restricted stock units (RSUs) with half vesting immediately and half vesting on the one-year anniversary. No other material financial or operational changes were disclosed.

• · Mr. Lutz was appointed as a Class B director with a term expiring at the 2027 annual meeting.
• · The RSU grant is subject to the Company's 2022 Equity Incentive Plan.
• · Mr. Lutz will be compensated per the Company's standard non-employee director fee practice as described in the 2025 Form 10-K.
• · There are no arrangements or transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-06-2026

UMH Properties, Inc. appointed Kevin Miller as Executive Vice President, Chief Financial Officer, and Treasurer effective June 1, 2026, and entered into an employment agreement with him on June 18, 2026. The agreement provides an annual base salary of $430,000, a target annual cash bonus of 60% of base salary, and eligibility for long-term equity awards under the 2023 Equity Incentive Award Plan. The initial term ends January 1, 2027, with automatic one-year renewals.

• · The Miller Agreement includes performance-based vesting for equity awards based on metrics such as normalized FFO per share growth, total shareholder return, same property occupancy increase, NOI growth, sale increase, acquisitions, development of sites, capital raising, and ESG
• · If terminated without cause (or for good reason/non-renewal), Miller receives three times the sum of base salary plus average annual bonus over the prior three years, paid in 36 monthly installments
• · In the event of termination due to death or disability, the multiplier is one time, paid in 12 monthly installments
• · Upon a change of control termination within 24 months, the Miller Termination Benefit is paid as a single lump sum within 60 days
• · Equity awards may be based in part on the Company's total shareholder return relative to the MSCI US REIT Index

23-06-2026

Anika Therapeutics held its 2026 Annual Meeting on June 18, 2026, where stockholders elected three Class III directors (Gary P. Fischetti, John B. Henneman III, and Stephen D. Griffin), ratified Deloitte & Touche as independent auditor, and approved executive compensation on a non-binding advisory basis. Stockholders also approved a sixth amendment and restatement of the 2017 Omnibus Incentive Plan, increasing authorized shares from 5,760,000 to 6,110,000, and an amendment to the 2021 Employee Stock Purchase Plan, doubling reserved shares from 200,000 to 400,000. Notably, while director elections and auditor ratification passed with strong support, the advisory vote on executive compensation and the incentive plan amendment received significant opposition (11.7% and 12.0% of votes cast against, respectively).

• · The Annual Meeting was held on June 18, 2026, with 84.14% voter turnout.
• · Proposal 1: All three director nominees were elected with strong support (Fischetti: 9,248,053 For; Henneman: 8,829,035 For; Griffin: 9,309,707 For).
• · Proposal 2: Ratification of Deloitte & Touche as auditor passed overwhelmingly (11,136,590 For, 24,966 Against).
• · Proposal 3: Advisory vote on executive compensation passed with 8,268,676 For, 1,093,946 Against, and 31,179 Abstain (excluding 1,801,866 broker non-votes).
• · Proposal 4: Incentive plan amendment passed with 8,013,994 For, 1,347,970 Against, and 31,837 Abstain (excluding 1,801,866 broker non-votes).
• · Proposal 5: ESPP amendment passed with 9,110,892 For, 257,394 Against, and 25,515 Abstain (excluding 1,801,866 broker non-votes).
• · The Revised Seventh Amended Plan increases authorized shares from 5,760,000 to 6,110,000 (a 350,000 share increase).
• · The ESPP amendment doubles reserved shares from 200,000 to 400,000.
• · No other provisions of the 2017 Plan or ESPP were amended.

23-06-2026

Sky Harbour Group Corporation held its 2026 Annual Meeting on June 18, 2026, where stockholders approved an amendment to the 2022 Incentive Award Plan, increasing the share reserve by 1,500,000 shares of Class A common stock. All seven director nominees were elected, and EisnerAmper LLP was ratified as the independent auditor for fiscal 2026. The say-on-pay proposal passed with strong support (over 49.6 million votes for), and stockholders selected a three-year frequency for future advisory votes on executive compensation.

• · The Amendment did not modify any other terms of the 2022 Incentive Award Plan.
• · Proposal 3 (Ratification of EisnerAmper LLP) received 57,642,943 votes for, 13,514 against, and 899 abstentions.
• · Proposal 4 (Say-on-Pay) received 49,634,762 votes for, 134,564 against, and 4,088 abstentions, with 7,883,942 broker non-votes.
• · Proposal 5 (Frequency of Future Advisory Votes) resulted in 46,178,244 votes for 3 years, 3,548,221 for 1 year, 7,189 for 2 years, and 39,760 abstentions.
• · The Board determined that future stockholder advisory votes on executive compensation will be held every three years.

23-06-2026

Fiserv completed a €1.0B dual-tranche Euro note offering on June 23, 2026, issuing €500M of 3.750% Senior Notes due 2030 and €500M of 4.250% Senior Notes due 2034. The notes are senior unsecured obligations and include customary change-of-control repurchase provisions at 101% of principal plus accrued interest. The offering was registered under an existing shelf registration statement.

• · The notes were issued under an Indenture dated November 20, 2007, as supplemented by a Thirty-Ninth Supplemental Indenture (2030 Notes) and a Fortieth Supplemental Indenture (2034 Notes).
• · Interest on the 2030 Notes is payable annually on October 15, beginning October 15, 2026; interest on the 2034 Notes is payable annually on June 23, beginning June 23, 2027.
• · The 2030 Notes mature on October 15, 2030; the 2034 Notes mature on June 23, 2034.
• · Prior to the par call date (September 15, 2030 for 2030 Notes; April 23, 2034 for 2034 Notes), the Company may redeem the notes at a make-whole premium plus accrued interest; on or after the par call date, redemption price is 100% of principal plus accrued interest.
• · Upon a change-of-control triggering event, the Company must offer to repurchase the notes at 101% of principal plus accrued interest.
• · Events of default include customary provisions; holders of at least 25% of principal of a series may accelerate that series upon a continuing event of default.
• · The offering was registered under Registration Statement No. 333-277241 (filed February 22, 2024, as amended).

23-06-2026

PRA Group held its 2026 Annual Meeting on June 16, 2026, where stockholders approved an amendment to the 2022 Omnibus Incentive Plan to increase the share limit by 3,500,000 shares. All nine director nominees were elected, and the appointment of Ernst & Young LLP as independent auditor for 2026 was ratified. However, the advisory vote on named executive officer compensation (Say-on-Pay) and the equity plan amendment each received notable opposition, with 6.9% and 17.0% of votes cast against, respectively.

• · Director Lance L. Weaver received the highest number of against votes among nominees (3,106,214 against), representing 9.7% of votes cast excluding broker non-votes.
• · Director Geir L. Olsen received 2,511,714 against votes (7.8% of votes cast excluding broker non-votes).
• · The ratification of Ernst & Young LLP as independent auditor passed with 99.6% of votes cast in favor (33,877,552 for, 146,010 against).
• · The equity plan amendment required a majority of votes cast and passed with 83.0% in favor (26,552,984 for, 5,442,103 against).
• · Broker non-votes totaled 2,029,734 on all director elections and the Say-on-Pay and equity plan proposals.

23-06-2026

F5, Inc. appointed Gavin Munroe to its board of directors effective June 17, 2026. Munroe, former CIO and Transformation Head at Commonwealth Bank of Australia, brings over 25 years of technology leadership in financial services and will serve on the Audit and Risk committees. The board expands to 10 members, 9 of whom are independent.

• · Munroe will serve on the Audit and Risk committees.
• · He most recently served as CIO and Transformation Head at Commonwealth Bank of Australia.
• · He has held technology leadership roles at HSBC, Bank of America/Merrill Lynch, Synechron, and Saxon (Morgan Stanley).
• · Munroe earned a Bachelor of Science in Computer Science from The University of Port Elizabeth.
• · F5 is the global leader in delivering and securing every app and API.

23-06-2026

IBM extended its $2.5B three-year revolving credit facility to June 20, 2029, with commitments from 21 lenders led by JPMorgan Chase. The extension was confirmed by the administrative agent on June 22, 2026, following an extension request from IBM. No negative or flat metrics are present in this filing.

• · The original credit agreement was dated June 22, 2021, and had been amended twice before (June 30, 2022 and June 20, 2025).
• · The extension request was delivered by IBM on June 2, 2026.
• · The new termination date for the extended commitments is June 20, 2029.
• · The largest individual commitments are $175M each from JPMorgan Chase, BNP Paribas, Citibank, and Royal Bank of Canada.
• · The smallest commitments are $84.375M each from eight lenders including Banco Bilbao Vizcaya Argentaria, Canadian Imperial Bank of Commerce, Goldman Sachs, Societe Generale, The Bank of Nova Scotia, The Toronto-Dominion Bank, Truist Bank, and U.S. Bank.

23-06-2026

Zoomcar Holdings, Inc. completed a second closing of its private placement on June 18, 2026, issuing 662 Series A Units at $1,000 per Unit for aggregate gross proceeds of approximately $537,000. The offering, conducted with accredited investors and placement agent ThinkEquity LLC, allows for up to $5,000,000 in Units plus an additional $5,000,000 overallotment option, with a minimum subscription threshold of $1,000,000 already satisfied. The Preferred Shares are convertible into common stock at $0.05 per share and the warrants have an exercise price of $0.0625 per share, expiring in five years.

• · The offering is scheduled to terminate on June 30, 2026, unless extended by the company.
• · Subscription amounts were held in escrow with CSC Delaware Trust Company pending the second closing.
• · The Preferred Shares have an initial conversion price of $0.05 per share, subject to adjustment including alternate conversion and price-reset provisions.
• · The Warrants have an exercise price of $0.0625 per share and expire five years from issuance.
• · The company must file a resale registration statement within 15 calendar days after the second closing and use best efforts to make it effective.
• · The Registration Rights Agreement includes partial liquidated damages if registration obligations are not met.
• · The securities were offered under Section 4(a)(2) and Rule 506(c) of Regulation D, relying on accredited investor status.
• · The company is an emerging growth company and has elected not to use the extended transition period for new accounting standards.

23-06-2026

Alto Ingredients held its 2026 Annual Meeting on June 23, 2026, where stockholders approved all four proposals: the election of five directors, the advisory say-on-pay resolution, the 2026 Omnibus Incentive Plan (authorizing up to 7,000,000 shares), and the ratification of RSM US LLP as independent auditor. The new equity plan replaces the prior plan and will remain in effect until 2036.

• · Director election results: Bryon T. McGregor received the most votes for (29,943,055); Dianne S. Nury received the most votes withheld (1,089,609).
• · Each director election had approximately 20.9 million broker non-votes.
• · Say-on-pay approval: 25,740,806 for vs. 1,044,080 against (93.4% of shares voted for).
• · 2026 Omnibus Incentive Plan approval: 25,660,172 for vs. 1,406,965 against (94.8% of shares voted for).
• · Ratification of RSM US LLP: 47,300,626 for vs. 1,027,058 against (97.9% of shares voted for); no broker non-votes on this proposal because it is a routine matter.
• · The 2026 Plan replaces the predecessor plan (not named) and no further awards will be made under the prior plan.
• · The 2026 Plan will remain in effect until June 23, 2036, unless terminated earlier.

23-06-2026

Worthington Enterprises reported fiscal Q4 2026 net sales of $371.5M, up 17% YoY, driven by $44.1M from acquisitions and 3% organic growth. Net earnings surged to $48.1M from $3.6M in the prior year quarter, while adjusted EPS declined to $0.97 from $1.06. For the full year, net sales rose 20% to $1.4B, adjusted EBITDA grew 12% to $295.8M, and the company completed acquisitions of Elgen Manufacturing and LSI Group. However, adjusted EBITDA in the Building Products segment decreased $2.7M due to lower equity income from ClarkDietrich and unfavorable product mix.

• · Q4 FY2026 operating income was $23.2M, up from a loss of $30.4M in Q4 FY2025, which included $52.2M in nonrecurring items primarily from a non-cash intangible asset write-down in the GTI business.
• · Equity in net income of unconsolidated affiliates decreased $4.6M to $38.1M, driven by a $6.8M decline from ClarkDietrich, partially offset by higher contributions from Workhorse and SES joint ventures.
• · Income tax expense increased to $11.7M from $4.7M, with an annual effective rate of 22.9% vs 26.1% in the prior year.
• · Total debt at quarter end was $305.9M, up $3.0M from May 31, 2025, due to remeasurement of euro-denominated notes; no borrowings under the $500M revolving credit facility.
• · Cash decreased $222.4M to $27.7M, primarily reflecting the acquisitions of Elgen and LSI.
• · Capital expenditures in Q4 included $6.6M for facility modernization projects expected to be completed in fiscal 2027.
• · Building Products adjusted EBITDA decreased $2.7M despite higher sales, due to lower ClarkDietrich equity income and unfavorable product mix.
• · Consumer Products net sales were essentially flat (+$0.6M), with higher average selling prices mostly offset by lower volume.
• · The company declared a quarterly dividend of $0.20 per share, a 5% increase from the prior quarter, payable September 29, 2026.
• · Full-year adjusted EBITDA grew 12% to $295.8M, and adjusted net earnings increased 8% to $167.6M.

23-06-2026

Team, Inc. announced the departure of CFO Nelson Haight effective June 22, 2026, and the appointment of Clinton Roeder as his successor. Haight will receive severance benefits including $603,750 in salary continuation, a prorated 2026 bonus, and accelerated equity vesting. Roeder brings over 30 years of financial experience and will receive a $500,000 base salary, a target bonus of 75% of base salary, and $500,000 in equity grants. The transition appears orderly with no disagreements cited, but the departure of a key executive introduces leadership transition risk.

• · Nelson Haight will serve as Special Advisor to the CEO from June 22 to July 3, 2026, receiving his normal base salary through that date.
• · Haight's outstanding unvested time-based RSUs will immediately vest; performance share units will continue to vest with payout prorated by 92%.
• · Clinton Roeder most recently served as EVP and CFO of PrimeFlight Aviation Services from May 2020 to May 2026.
• · Roeder's equity grant is split 30% RSUs (3-year vesting) and 70% PSUs (cliff vest Dec 31, 2028 based on 3-year Adjusted EBITDA).
• · No family relationships or material interests in transactions were reported for Roeder.

23-06-2026

Fastenal Company entered into a Second Amended and Restated Credit Agreement dated June 18, 2026, establishing an $835,000,000 revolving credit facility with Wells Fargo Bank as Administrative Agent, Swingline Lender, and Issuing Lender, and Wells Fargo Securities and PNC Capital Markets as Joint Lead Arrangers. The facility replaces the prior Amended and Restated Credit Agreement dated September 28, 2022, and includes pricing grids tied to the Consolidated Total Leverage Ratio, with margins ranging from 1.000% to 1.375% over Term SOFR and commitment fees from 0.100% to 0.175%.

• · The credit agreement includes a provision for incremental increases in commitments (Section 4.13).
• · The facility matures on the Revolving Maturity Date, with an extension option under Section 4.16.
• · Financial covenants include a Consolidated Total Leverage Ratio test (Section 8.4).
• · The agreement contains standard representations, affirmative and negative covenants, and events of default.
• · The pricing grid adjusts quarterly based on the Borrower's Consolidated Total Leverage Ratio, with a fallback to Pricing Level IV if compliance certificates are not timely delivered.

23-06-2026

CIMG Inc. entered into securities purchase agreements on June 17, 2026, to issue up to 43.33 billion units at $0.015 per unit for aggregate gross proceeds of up to $650 million, payable in Bitcoin or USD. The initial closing on June 22, 2026, raised approximately $13.5 million through the issuance of 900 million units, with all related warrants exercised, resulting in 1.8 billion shares issued. However, the massive dilution from the potential issuance of up to 43.33 billion shares raises significant concerns for existing shareholders.

• · The warrants have a two-year exercise period from issuance and can be exercised for cash in USD or Bitcoin.
• · The purchase price in Bitcoin is based on a reference price of $65,000 per Bitcoin unless otherwise agreed.
• · Stockholder approval was obtained on December 24, 2025, for Nasdaq Listing Rule 5635(d) compliance.
• · The offering was made under a registration statement on Form S-1 (SEC File No. 333-294624).

23-06-2026

QuidelOrtho Corp appointed Micah Young as CFO effective July 6, 2026, succeeding Joseph M. Busky who is retiring. Young brings over two decades of leadership experience from Masimo Corp and other medical technology firms. The change is a standard leadership transition with no financial performance data disclosed.

• · Micah Young previously served as Executive Vice President and CFO of Masimo Corporation (2017-2026).
• · Joseph Busky previously announced his retirement and will stay in an advisory role.
• · Mr. Young holds a Bachelor of Science in Accounting and Criminal Justice from Indiana Wesleyan University and is a CPA (inactive).

23-06-2026

Burke & Herbert Financial Services Corp. appointed Roy E. Halyama, current EVP and CFO, as President of the Company and Burke & Herbert Bank & Trust, effective July 1, 2026, following the retirement of H. Charles Maddy, III on June 30, 2026. No modifications to Mr. Halyama's compensation were made in connection with the appointment.

• · Mr. Halyama, age 58, has served as EVP and CFO since joining the company in 2021.
• · Prior to BHRB, he was CFO of a PNC affiliate from 2019 to 2021.
• · He holds a BS in Business Administration/Accounting and an MBA in Finance from The Ohio State University.
• · No family relationships exist between Mr. Halyama and any director or executive officer.
• · No arrangements or understandings exist regarding his appointment, and no transactions under Item 404(a) are reportable.

23-06-2026

Beazer Homes USA, Inc. closed its offering of $400 million 8.000% Senior Unsecured Notes due 2032. The net proceeds will refinance $357.3 million of the company's 5.875% Senior Notes due 2027, with the remainder used for general corporate purposes.

• · The offering was private, exempt from SEC registration under Rule 144A and Regulation S.
• · Any remaining proceeds after redeeming the 2027 Notes will be used for general corporate purposes.
• · Beazer Homes is headquartered in Atlanta, Georgia, and builds homes in 13 states: Arizona, California, Delaware, Florida, Georgia, Indiana, Maryland, Nevada, North Carolina, South Carolina, Tennessee, Texas, and Virginia.
• · The company highlights energy-efficient construction and a Mortgage Choice program offering multiple lender options.

23-06-2026

PG&E Corp and its subsidiary Pacific Gas and Electric Company entered into amendments to their revolving credit agreements on June 22, 2026. The utility subsidiary's credit facility was increased from $5.4B to $6.25B and its maturity extended to June 20, 2031, while the parent company's facility maturity was extended to June 22, 2029 with modified pricing and collateral release terms tied to achieving investment-grade credit ratings.

• · The Utility Amendment extended the maturity date to June 20, 2031.
• · The Corporation Amendment extended the maturity date to June 22, 2029.
• · Collateral release for the Corporation facility requires senior unsecured investment grade ratings from at least two agencies, no Event of Default, and secured indebtedness ≤ $250M.
• · The lien on collateral will be reinstated if PG&E Corp fails to maintain investment grade ratings from at least two agencies or has more than $250M of secured indebtedness outstanding.

23-06-2026

UroGen Pharma Ltd. filed an 8-K on June 23, 2026, to adopt amended Articles of Association, updating governance provisions including share issuance authority, class rights modification, and capital structure flexibility. The changes codify existing practices under Israeli law and NASDAQ rules, with no immediate financial impact. No material operational or financial metrics were disclosed, and investor rights remain largely unchanged.

• · Ordinary shares have nominal value of NIS 0.01 each.
• · Board is authorized to issue shares, options, warrants, or other securities without shareholder approval, subject to applicable law.
• · Company may donate reasonable amounts even if not for business purposes.
• · Shares are uncertificated unless the Board decides otherwise.
• · Transfer of shares requires proper instrument; DTC shares transfer per DTC policies.

23-06-2026

At its 2026 Annual Meeting on June 22, 2026, Schrödinger, Inc. stockholders approved an amendment to the 2022 Equity Incentive Plan, increasing authorized shares by 3,000,000, and ratified KPMG LLP as independent auditor for FY 2026. All four proposals passed, including the advisory vote on executive compensation with strong support (51.3M shares FOR vs 0.9M AGAINST). However, the equity plan amendment faced notable opposition, with 10.8M shares (20.7% of votes cast) voting against it, and director Rosana Kapeller-Libermann received the lowest support among the three Class III director nominees, with 10.7M shares (24.9% of votes cast) voting against her election.

• · The 2026 Annual Meeting was held on June 22, 2026.
• · Stockholders approved the 2026 Plan Amendment, increasing the share reserve by 3,000,000 shares.
• · KPMG LLP was ratified as the independent registered public accounting firm for FY 2026 with 61,674,114 shares FOR and only 179,559 AGAINST.
• · The advisory vote on executive compensation passed with 51,345,375 shares FOR and 870,926 AGAINST.
• · Director Rosana Kapeller-Libermann received the lowest support among nominees: 32,336,273 FOR vs 10,723,565 AGAINST (24.9% against).
• · The equity plan amendment had 10,825,547 shares AGAINST (20.7% of votes cast), indicating notable shareholder dissent.
• · Broker non-votes totaled 9,593,955 shares on director elections and advisory proposals.

23-06-2026

On June 16, 2026, the Board of Directors of Neuronetics, Inc. promoted Cory Anderson from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook, effective July 1, 2026. The promotion includes an increase in annual base salary to $425,000 and a target discretionary annual cash bonus of 45% of base salary. The filing does not disclose any negative or declining metrics.

• · The promotion is effective July 1, 2026.
• · Mr. Anderson, age 49, has over 25 years of experience in medical device companies.
• · He previously served as SVP R&D and Clinical, CTO since January 2025; SVP R&D and Clinical from January 2023 to December 2024; VP R&D and Clinical from January 2022 to December 2022; and VP Clinical Affairs and Medical Operations, Interim VP R&D from March 2021 to December 2021.
• · He holds Bachelor's and Master's degrees in Biomedical Engineering from Tulane University and an MBA from Emory University.
• · He is an inventor on seven issued U.S. patents and author of two peer-reviewed papers and one book chapter.
• · Mr. Anderson had previously entered into the Company's executive indemnification agreement, executive restrictive covenant and severance agreement, and restrictive covenant and invention assignment agreement.
• · There are no family relationships or related party transactions requiring disclosure under Item 404(a) of Regulation S-K.

23-06-2026

NNN REIT, Inc. entered into a First Amendment to its Term Loan Agreement on June 23, 2026, securing an additional $200,000,000 in term loans from existing lenders including Wells Fargo, Bank of America, and PNC Bank. The amendment also updates the Applicable Margin pricing grid tied to the company's credit rating, with margins ranging from 0.675% to 1.550% for SOFR loans. The company reaffirmed that no Material Adverse Change has occurred since December 31, 2025, and no Default or Event of Default exists.

• · The additional loans are due and payable in full on the Termination Date and cannot be reborrowed once repaid or prepaid.
• · Proceeds from the additional loans will be used in accordance with Section 7.7 of the Term Loan Agreement.
• · The amendment was executed by the Borrower, Administrative Agent (Wells Fargo), and each Incremental Lender, with conditions precedent including delivery of legal opinions, Notes, and a Notice of Borrowing.
• · The Borrower reaffirmed that its representations and warranties in the Loan Documents remain true and correct in all material respects as of the Effective Date.
• · The agreement is governed by the laws of the State of New York.

23-06-2026

SharpLink Gaming, Inc. (SBET) announced a $75 million registered direct offering priced at $7.49 per share and warrant, representing a 41% premium to its last closing price of $5.29. The company, which holds 875,776 ETH, plans to use proceeds for working capital, additional ETH accumulation, and share repurchases. While the premium pricing signals strong investor confidence, the offering dilutes existing shareholders by 10,013,351 shares, and the company's reliance on volatile ETH holdings introduces significant financial risk.

• · The offering is being made under an effective shelf registration statement on Form S-3ASR (File No. 333-287708) declared effective on May 30, 2025.
• · The warrants have an exercise price of $8.15 per share, are exercisable immediately, and expire four years from issuance.
• · The company intends to use net proceeds for working capital, additional ETH accumulation, and share repurchases under its stock repurchase program.
• · SharpLink describes itself as 'one of the world’s largest corporate holders of Ether' and an 'institutional-grade Ethereum treasury platform.'
• · The company also operates an online affiliate marketing business in addition to its Ethereum treasury platform.

23-06-2026

BJ's Restaurants, Inc. (BJRI) disclosed in an 8-K filing that its Board of Directors approved amended compensation for non-employee directors, effective June 17, 2026. The changes include increases to annual cash retainers and restricted stock unit awards, with the base cash retainer rising by $5,000 to $80,000 and the annual RSU award increasing by $15,000 to $140,000. The adjustments reflect modest incremental increases across committee retainers and chair roles, with no declines or flat metrics noted.

• · The compensation changes were approved upon recommendation of the Compensation Committee and its compensation consultant.
• · The annual RSU award vests one year from the date of grant, with share count determined by the average closing price over 20 trading days ending on the grant date.
• · Finance Committee compensation will be paid in arrears to the date the committee was first established.
• · New non-employee directors receive a prorated initial equity award effective the beginning of the quarter they join the Board.
• · The filing was signed on June 23, 2026, by Lyle D. Tick, CEO and President.

23-06-2026

Jewett-Cameron Trading Company Ltd. announced the retirement of Independent Director Ian Wendler from its Board of Directors, effective July 31, 2026. Mr. Wendler's departure is not due to any disagreement with the company, and a search to fill the resulting vacancy has been initiated. The filing contains no financial data or performance metrics.

• · Mr. Wendler was originally appointed to the Board in December 2023 and was reelected at the Shareholder's Meeting on February 27, 2026.
• · Mr. Wendler currently serves as a member of the Audit Committee.
• · The company is initiating a search to fill the vacancy left by Mr. Wendler's departure.

23-06-2026

Upwork Inc. entered into a $150 million revolving credit facility with Bank of America as administrative agent, swingline lender, and L/C issuer, along with other lenders. The agreement includes customary covenants, interest rate margins based on leverage ratios, and provisions for letters of credit and swingline loans. No prior-period financial data is provided in this filing, so period-over-period comparisons are not available.

• · The credit agreement includes a $150 million aggregate revolving commitment as of the closing date.
• · Initial Applicable Margin is set at Pricing Level 2 until the first compliance certificate is delivered.
• · Pricing levels are determined by the Consolidated Net Leverage Ratio, with three tiers: <0.75:1.00, 0.75:1.00 to <1.50:1.00, and >1.50:1.00.
• · The agreement includes provisions for incremental facility loans, letters of credit, and swingline loans.
• · The facility is secured by certain subsidiaries as guarantors and includes customary affirmative and negative covenants.
• · No financial performance data (revenue, earnings, etc.) is disclosed in this filing.

23-06-2026

IFF entered into a $1.5B Term Loan Credit Agreement on June 23, 2026, with Wells Fargo as agent and a syndicate of lenders including Bank of America, Barclays, BNP Paribas, Citibank, and JPMorgan. The facility is a delayed draw term loan with an availability period ending September 25, 2026, and proceeds are intended for general corporate purposes. The interest rate is tied to IFF's public debt rating, with margins ranging from 0.875% to 1.500% for Term Benchmark Rate Advances and 0.000% to 0.500% for Base Rate Advances.

• · The facility is a delayed draw term loan with an availability period from June 23, 2026 to September 25, 2026.
• · The agreement includes a financial covenant (Section 5.03) but the specific covenant details are not provided in the excerpt.
• · The interest rate margins are determined by IFF's public debt rating from S&P and Moody's, with five levels ranging from Level 1 (A-/A3 or above) to Level 5 (below BBB-/Baa3).
• · The agreement references '2026 Euro Notes Indebtedness' of €1.800% Senior Notes due 2026, indicating existing euro-denominated debt.

23-06-2026

Ashford Hospitality Trust completed the sale of the 254-room Hilton Garden Inn Austin Downtown for approximately $26.4 million in net cash proceeds, using $25.7 million to repay a mortgage loan secured by 17 hotels. The pro forma financials show the disposition reduces total assets by $28.5 million and total liabilities by $33.7 million, while improving the net loss attributable to common stockholders from $(215.0) million to $(205.2) million for FY2025 and from $(71.1) million to $(48.8) million for Q1 2026. However, the company continues to report significant net losses and negative equity of $(675.1) million on a pro forma basis.

• · The mortgage loan repaid is secured by 17 hotels, including HGI Austin.
• · Pro forma net loss attributable to common stockholders improved from $(35.99) per share to $(34.35) per share for FY2025, and from $(11.03) to $(7.58) for Q1 2026.
• · The pro forma gain on disposition is preliminary and actual results may differ.
• · The company's pro forma total equity (deficit) remains negative at $(675.1) million.
• · No material tax effect was recorded for FY2025; a $43,000 tax benefit adjustment was made for Q1 2026.

23-06-2026

Jack in the Box Inc. completed a $500 million securitized financing facility through the sale of Series 2026-1 7.624% Fixed Rate Senior Secured Notes, Class A-2, with net proceeds used to repay existing Series 2019-1 4.476% notes and a portion of Series 2022-1 3.445% notes. The company also entered into a $150 million variable funding note facility to replace its existing revolving credit line. While the refinancing extends maturities to 2029 and supports the 'JACK on Track' plan, the new fixed-rate notes carry a significantly higher interest rate (7.624%) compared to the replaced notes (4.476% and 3.445%), increasing interest expense.

• · The new fixed-rate notes carry a 7.624% interest rate, significantly higher than the 4.476% and 3.445% rates on the replaced notes.
• · The next anticipated repayment date is in 2029, clearing near-term maturities.
• · The $150 million variable funding note facility replaces the existing $150 million Series 2022-1 Variable Funding Senior Secured Notes, Class A-1.
• · Jack in the Box operates approximately 2,128 restaurants across 24 states, Guam and Mexico.

23-06-2026

Talphera, Inc. held its 2026 Annual Meeting on June 22, 2026, where stockholders elected three Class III directors (Marina Bozilenko, Joseph Todisco, Mark Wan) and ratified BPM LLP as independent auditor for fiscal 2026. Stockholders also approved, on an advisory basis, executive compensation, and approved amendments to the 2020 Equity Incentive Plan and the 2011 Employee Stock Purchase Plan. All proposals passed with strong support, though broker non-votes were significant on director elections and compensation-related items.

• · Broker non-votes totaled 7,732,743 on director elections and compensation-related proposals, representing about 24.6% of shares voted.
• · Proposal 2 (ratification of auditor) passed with 31,019,362 votes for, 356,608 against, and 60,967 abstentions, with no broker non-votes.
• · Proposal 3 (advisory vote on executive compensation) received 22,874,586 for, 786,249 against, and 43,359 abstentions.
• · Proposal 4 (2020 EIP amendment) received 22,602,504 for, 1,068,623 against, and 33,067 abstentions.
• · Proposal 5 (2011 ESPP amendment) received 23,020,334 for, 657,322 against, and 26,538 abstentions.
• · The filing date is June 23, 2026, and the meeting date was June 22, 2026.

23-06-2026

Aditxt, Inc. entered into Amendment No.1 to its Note Purchase Agreement on June 22, 2026, increasing the aggregate principal amount of senior secured convertible notes from the prior amount to $6,254,355.17 and issued an additional $769,230.77 in principal amount of notes for $500,000 in cash to investor Cavalry Fund I SPV I LP. The notes are secured by substantially all assets of subsidiary Ignite Proteomics LLC and a pledge of the Company's equity in Ignite.

• · The Amendment was executed on June 22, 2026, and filed with the SEC on June 23, 2026.
• · The Additional Notes were issued pursuant to exemptions under Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
• · The notes are further secured by a pledge of all equity held by Aditxt in Ignite Proteomics LLC.
• · The Amendment also adjusted the definition of 'Closing' and 'Closing Date' to include the additional closing.
• · The previously announced original principal amount in the June 3, 2026 Note Purchase Agreement was $6,638,970.55 (as stated in the amendment), but the filing states the amended aggregate is $6,254,355.17, implying a possible reduction or netting; the exact relationship is not clarified in this filing.

23-06-2026

NIKE, Inc. announced that David M. Denton will join as Executive Vice President and CFO effective August 17, 2026, succeeding Matthew Friend, who will step down and support the transition through September 4. The company also provided an update on expected Q4 fiscal 2026 results, which will include a one-time benefit from tariff refunds not previously contemplated in guidance, while results excluding that benefit are expected to be generally in line with prior guidance.

• · Denton joins from Pfizer, where he served as CFO and EVP since May 2022.
• · Denton previously served as CFO and EVP of Lowe's Companies from 2018 to 2022.
• · Denton spent two decades at CVS Health, including as EVP and CFO.
• · Denton previously served on the boards of Haleon (2023–2024) and Tapestry (2014–2023), and is expected to serve on the board of Honeywell Aerospace after its spin-off.
• · Matthew Friend will participate in the Q4 fiscal 2026 earnings call on June 30 as planned.
• · The Q4 fiscal 2026 results will be reported on June 30, 2026.

23-06-2026

FDCTech, Inc. announced on June 23, 2026 that its previously issued unaudited interim financial statements for the three, six, and nine months ended March 31, June 30, and September 30, 2024 should no longer be relied upon due to multiple accounting errors. The errors include misclassification of client funds, related party cash credits, subscription receivables, intercompany eliminations, omission of 500,000 shares, and foreign currency translation adjustments. The restated information is available in the company's fiscal year 2025 Quarterly Reports, and management has identified material weaknesses in internal controls.

• · The non-reliance determination covers the unaudited condensed consolidated financial statements for the three months ended March 31, 2024, the three and six months ended June 30, 2024, and the three and nine months ended September 30, 2024.
• · Errors include misclassification of client funds of Alchemy Prime Limited and Alchemy Markets Ltd. within cash, misclassification of related party cash credits as cash on hand, misclassification of a subscription receivable as a current asset rather than contra-equity, intercompany elimination errors, omission of 500,000 shares of common stock issued in October 2021, and errors in foreign currency translation adjustment and allocation between controlling and noncontrolling interests.
• · The restated financial information is presented as comparative prior-period information in the company's Quarterly Reports on Form 10-Q for the corresponding interim periods of fiscal year 2025.
• · Management identified material weaknesses in internal control over financial reporting in connection with the restatements.
• · The Board, which performs the functions of an audit committee, discussed the matters with LAO, the current independent registered public accounting firm.

23-06-2026

Hayward Holdings, Inc. entered into an Amended and Restated First Lien Credit Agreement dated June 23, 2026, amending and restating the original First Lien Credit Agreement from September 28, 2018. The agreement involves Hayward Industries, Inc. as US Borrower, Hayward Pool Products Canada, Inc. as Canadian Borrower, and Hayward Intermediate, Inc. as Holdings, with Bank of America, N.A. as Administrative Agent and a syndicate of lenders including Goldman Sachs, JPMorgan, MUFG, Truist, U.S. Bank, and Wells Fargo. The agreement establishes revolving credit facilities and term loans, with provisions for incremental credit extensions, financial covenants, and events of default.

• · The agreement amends and restates the original First Lien Credit Agreement dated September 28, 2018, which had been amended multiple times (October 2020, May 2021, December 2022, May 2023).
• · The agreement includes provisions for incremental credit extensions (Section 2.22) and extensions of loans and additional revolving commitments (Section 2.23).
• · The agreement contains financial covenants (Section 6.15) and events of default (Article VII).
• · The agreement includes a provision for cashless rollovers (Section 1.09).

23-06-2026

Emanuel "Manny" Chirico informed Conagra Brands on June 22, 2026 that he will not stand for reelection to the Board of Directors at the 2026 Annual Meeting in September, though he will serve through the remainder of his current term. The departure is not due to any disagreement with the Board or the Company.

• · Emanuel Chirico will continue to serve through the remainder of his current term.
• · The 2026 Annual Meeting of Shareholders is scheduled for September 2026.
• · The decision was not due to any disagreement with the Board or the Company.